1. Home
  2. BLTE vs VIAV Comparison

BLTE vs VIAV Comparison

Compare BLTE & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • VIAV
  • Stock Information
  • Founded
  • BLTE 2018
  • VIAV 1923
  • Country
  • BLTE United States
  • VIAV United States
  • Employees
  • BLTE N/A
  • VIAV N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • VIAV Semiconductors
  • Sector
  • BLTE Health Care
  • VIAV Technology
  • Exchange
  • BLTE Nasdaq
  • VIAV Nasdaq
  • Market Cap
  • BLTE 2.6B
  • VIAV 2.7B
  • IPO Year
  • BLTE 2022
  • VIAV 1993
  • Fundamental
  • Price
  • BLTE $93.82
  • VIAV $13.95
  • Analyst Decision
  • BLTE Strong Buy
  • VIAV Buy
  • Analyst Count
  • BLTE 4
  • VIAV 8
  • Target Price
  • BLTE $96.00
  • VIAV $13.35
  • AVG Volume (30 Days)
  • BLTE 69.4K
  • VIAV 2.6M
  • Earning Date
  • BLTE 11-11-2025
  • VIAV 10-29-2025
  • Dividend Yield
  • BLTE N/A
  • VIAV N/A
  • EPS Growth
  • BLTE N/A
  • VIAV N/A
  • EPS
  • BLTE N/A
  • VIAV 0.15
  • Revenue
  • BLTE N/A
  • VIAV $1,084,300,000.00
  • Revenue This Year
  • BLTE N/A
  • VIAV $12.24
  • Revenue Next Year
  • BLTE N/A
  • VIAV $3.94
  • P/E Ratio
  • BLTE N/A
  • VIAV $91.67
  • Revenue Growth
  • BLTE N/A
  • VIAV 8.39
  • 52 Week Low
  • BLTE $49.00
  • VIAV $8.10
  • 52 Week High
  • BLTE $93.59
  • VIAV $13.92
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 77.42
  • VIAV 73.61
  • Support Level
  • BLTE $88.00
  • VIAV $13.01
  • Resistance Level
  • BLTE $91.92
  • VIAV $13.46
  • Average True Range (ATR)
  • BLTE 3.16
  • VIAV 0.33
  • MACD
  • BLTE 0.90
  • VIAV 0.06
  • Stochastic Oscillator
  • BLTE 98.97
  • VIAV 97.73

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

Share on Social Networks: